Exchange: NYSE·Updated 04:00 AM EDT

PACS News

News
all
press releases
PACS Group Announces Chief Legal Officer Transition
PACS Group, Inc. (PACS or the Company) announced today that John Mitchell has retired, effective Sept. 18, 2026, from his position as Chief Legal Officer and Corporate Secretary. Following his retirement, Mitchell will serve as a consultant to PACS to support an orderly leadership transition. This...
Business Wire
More News
PACS Group, Inc. to Present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026
PACS Group, Inc. (NYSE: PACS) (PACS or the Company), announced today that it will present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026, in Nashville, TN.Jason Murray, Chief Executive Officer and Chairman of the Board; Carey Hendrickson, Chief Financial...
Business Wire
PACS Expands Florida Footprint With 32-Facility Acquisition
PACS plans to acquire operations of 32 Florida skilled nursing facilities, adding 4,049 licensed beds and establishing a statewide network.
Zacks
Here's Why Ensign Group Stock Remains a Buy for Investors
Ensign Group's rising occupancy, acquisitions and real-estate growth support its outlook, while reimbursement and cost pressures remain risks.
Zacks
Zacks Industry Outlook CareDx, BrightSpring and PACS
CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.
Zacks
3 Medical Service Stocks Resilient Amid Persistent Workforce Shortage
CareDx, BrightSpring and PACS Group are positioned for growth as digital health expands and workforce shortages reshape medical services.
Zacks
Wall Street Analysts See a 25.73% Upside in PACS Group, Inc. (PACS): Can the Stock Really Move This High?
The consensus price target hints at a 25.7% upside potential for PACS Group, Inc. (PACS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
Biodesix, Inc. (BDSX) Hit a 52 Week High, Can the Run Continue?
Biodesix (BDSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks
PACS Group, Inc. (PACS) Surpasses Q2 Earnings and Revenue Estimates
PACS Group, Inc. (PACS) delivered earnings and revenue surprises of +14.55% and +1.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
PACS Group, Inc. Reports Second Quarter 2026 Results
PACS Group, Inc. (NYSE: PACS) (PACS or the Company), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the second quarter of 2026. Second Quarter 2026 Financial Highlights Revenue was $1.43 billion, an...
Business Wire

Advertisement|Remove ads.